search
cancer treatment
Trends
- 1
A melanoma vaccine built on mRNA technology is in the news, with health outlets highlighting it as a promising new approach to treating the deadliest form of skin cancer. mRNA vaccines, proven at scale during the COVID-19 pandemic, are being developed to train the immune system to recognise and attack cancer cells, with several candidates now in clinical trials.
- 2Researchers link cell crowding to optimal treatment timing●Treatment resistance is one of the key challenges in cancer and antibiotic therapy. Researchers led by Dr. Jona Kayser a
Researchers led by Dr. Jona Kayser at MPZPM report that physical processes in dense cell populations strongly influence the best timing of treatment cycles, with implications for both cancer therapy and antibiotics. Treatment resistance remains one of the central challenges in medicine, and the findings suggest that timing could be adjusted based on how tightly cells pack together rather than on biology alone. The work points to new ways of scheduling therapies to delay or avoid resistance.
- 313-Year-Old Reported Cured of DIPG, Deadliest Childhood Brain Cancer●A 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old has reportedly become the first person cured of DIPG, an incurable and almost universally fatal childhood brain cancer. News of the case, described as a world first, has spread widely online, with readers reacting to the prospect of a breakthrough against a disease that has long defied treatment and typically claims young patients' lives within months of diagnosis.
- 4UConn Health Launches CAR-T Cell Therapy Program▼UConn Health Launches Cutting-Edge CAR-T Cell Therapy Program
UConn Health has announced the launch of a new CAR-T cell therapy program, a form of immunotherapy that engineers a patient's own immune cells to fight cancer. The initiative brings an advanced, personalised cancer treatment to the Connecticut institution, expanding access for patients in the region who previously had to travel elsewhere for such therapy.
- 5Proliferative Pause Offers Window to Prevent Brain Metastasis▼Proliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that cancer cells entering a 'proliferative pause' — a dormant, slow-dividing state — may expose a critical window during which brain metastasis could be prevented. The finding suggests that targeting cells during this quiescent phase, before they resume growth in the brain, could open new preventive strategies against one of the deadliest consequences of cancer spread.
- 6Theoretical physics sheds light on tumour DNA mechanisms●Theoretical physics helps unveil the molecular mechanisms of extra-chromosomal DNA in tumours
Researchers, including Italy's National Institute for Nuclear Physics, report that theoretical physics methods have helped reveal how extra-chromosomal DNA behaves inside tumour cells. These circular DNA fragments, separate from chromosomes, are known to drive cancer growth and drug resistance. Applying physics-based modelling to their molecular mechanisms offers new insight that could inform future cancer research and treatment strategies.
- 7
New research suggests that analysing the biology of prostate cancer tumours can help doctors identify which patients are most likely to benefit from hormone therapy. The findings could support more personalised treatment decisions, allowing clinicians to target therapy at those most likely to respond rather than applying it universally. The report has drawn attention in medical news coverage.
- 8Penn Medicine and IBA Launch Proton Therapy Joint Venture▼Penn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian proton therapy company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will focus on developing and expanding access to advanced cancer radiation treatments. Details on investment size, timeline and specific projects have not been announced, and the companies have not yet outlined how the venture will operate alongside existing clinical programs.
- 9Building AI for Cancer Care in Somaliland▼Building AI for Cancer Care in SomalilandBuilding AI for Cancer Care in Somaliland
A new initiative is exploring the use of artificial intelligence to improve cancer care in Somaliland, where diagnostic infrastructure and oncology services remain limited. The effort, highlighted in professional medical circles, focuses on adapting AI tools to local healthcare needs, aiming to support earlier detection and treatment decisions in a region with few specialists. It reflects a growing interest in applying AI to low-resource health systems.